Meeting
2022 ASCO Annual Meeting
Evaluating the impact of perioperative antibiotic prophylaxis on the microbiome in patients with cutaneous malignancy.
Authors
Samuel Cass
The University of Texas MD Anderson Cancer Center, Houston, TX
Samuel Cass , Russell G. Witt , Xialong Meng , Pranoti Sahasrabhojane , Roland L. Bassett Jr., Samuel Shelburne , Hsiu Yin Chang , Kinjal Somaiya , Kristi Mungovan , Sarah B. Fisher , Anthony Lucci , Jeffrey Edwin Lee , Merrick I. Ross , Jeffrey E. Gershenwald , Sheila Duncan , Nadim J. Ajami , Christina Lynn Roland , Jennifer Ann Wargo , Emily Zhi-Yun Keung
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Biologic Correlates
Clinical Trial Registration Number
NCT04875728
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr TPS9602)
DOI
10.1200/JCO.2022.40.16_suppl.TPS9602
Abstract #
TPS9602
Poster Bd #
189b
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Optimization of Voyager V1 (VV1) oncolytic virus systemic delivery in combination with cemiplimab and ipilimumab in patients with melanoma and non–small cell lung cancer (NSCLC).
First Author: Jose Lutzky
Poster
2014 Genitourinary Cancers Symposium
Prevalence and adverse impact of extended antibiotic prophylaxis in urologic oncology surgery.
First Author: Matthew Mossanen
Poster
2012 ASCO Annual Meeting
Gene expression profile signature (DecisionDx-Melanoma) to predict visceral metastatic risk in patients with stage I and stage II cutaneous melanoma.
First Author: Navneet Dhillon
Poster
2024 ASCO Annual Meeting
Polyploid circulating stromal cells in blood to identify invasive solid tumors and to prognosticate for highly aggressive cancer subtypes.
First Author: Daniel L Adams